{"organizations": [], "uuid": "b1d87548c04a38522fdd3b5faaaca42a695684e0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 50, "shares": 50, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "https://fm.cnbc.com/applications/cnbc.com/resources/img/editorial/2017/07/25/104608923-GettyImages_r-669889770.1910x1000.jpg", "site_section": "", "section_title": "", "url": "https://www.cnbc.com/2018/02/18/facebook-still-testing-users-patience-while-rewarding-investors.html", "country": "US", "domain_rank": 767, "title": "Facebook still testing users' patience, while rewarding investors", "performance_score": 0, "site": "cnbc.com", "participants_count": 0, "title_full": "", "spam_score": 0.633, "site_type": "news", "published": "2018-02-19T00:25:00.000+02:00", "replies_count": 0, "uuid": "b1d87548c04a38522fdd3b5faaaca42a695684e0"}, "author": "John Shinal", "url": "https://www.cnbc.com/2018/02/18/facebook-still-testing-users-patience-while-rewarding-investors.html", "ord_in_thread": 0, "title": "Facebook still testing users' patience, while rewarding investors", "locations": [], "entities": {"persons": [{"name": "jim carrey", "sentiment": "none"}, {"name": "mark zuckerberg", "sentiment": "none"}, {"name": "roger mcnamee", "sentiment": "none"}, {"name": "chamath palihapitiya", "sentiment": "none"}, {"name": "zuckerberg", "sentiment": "none"}], "locations": [], "organizations": [{"name": "getty images mark zuckerberg  facebook", "sentiment": "neutral"}, {"name": "facebook", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Facebook is still requiring a lot of patience from some users, even after Mark Zuckerberg has pledged to make product changes amid the company's struggle to combat fake news, hate speech and Russian misinformation.\nWithin the last week, it was still flooding users' phones with annoying texts , in some cases in reply to a request related to an important security feature known as two-factor authentication.\nFacebook also defended its decision to roll out Messenger Kids using testimonials from child experts that it had funded. The pharmaceutical industry has been doing the same thing for decades, of course, by paying researchers who tout its medical devices and drugs.\nBut many Facebook users-turned-critics â€” including early investors like Roger McNamee , former employees like", "external_links": [], "published": "2018-02-19T00:25:00.000+02:00", "crawled": "2018-02-19T00:25:15.000+02:00", "highlightTitle": ""}